Average Co-Inventor Count = 5.87
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (21 from 4,958 patents)
2. F. Hoffmann-La Roche Ag (169 patents)
21 patents:
1. 12060333 - Aminocarbamoyl compounds for the treatment of viral infections
2. 12012390 - Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease
3. 11993591 - Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease
4. RE49481 - Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
5. 11242345 - Sulfonimidoylpurinone compounds and methods of treatment using the same
6. 11220502 - Sulfone compounds and derivatives for the treatment and prophylaxis of virus infection
7. 10752630 - 7-substituted sulfonimidoylpurinone compounds for the treatment of virus infection
8. 10399983 - Sulfonimidoylpurinone compounds
9. 10336751 - Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
10. 10233184 - 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
11. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
12. 9949966 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
13. 9902701 - Pyridazones and triazinones for treatment and prophylaxis of hepatitis B virus infection
14. 9790213 - Imidazoles for the treatment and prophylaxis of respiratory syncytial virus infection
15. 9708325 - Sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection